Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/136331
Full metadata record
DC FieldValueLanguage
dc.creatorPezzani, R
dc.creatorSalehi, B
dc.creatorVitalini, S
dc.creatorIriti, M
dc.creatorZuñiga, FA
dc.creatorSharifi-Rad, J
dc.creatorMartorell, M
dc.creatorMartins, N
dc.date.accessioned2021-09-20T10:53:10Z-
dc.date.available2021-09-20T10:53:10Z-
dc.date.issued2019
dc.identifier.issn1010-660X
dc.identifier.urihttps://hdl.handle.net/10216/136331-
dc.description.abstractSynergy is a process in which some substances cooperate to reach a combined effect that is greater than the sum of their separate effects. It can be considered a natural “straight” strategy which has evolved by nature to obtain more efficacy at low cost. In this regard, synergistic effects may be observed in the interaction between herbal products and conventional drugs or biochemical compounds. It is important to identify and exploit these interactions since any improvement brought by such kind of process can be advantageously used to treat human disorders. Even in a complex disease such as cancer, positive synergistic plant-drug interactions should be investigated to achieve the best outcomes, including providing a greater benefit to patients or avoiding adverse side effects. This review analyzes and summarizes the current knowledge on the synergistic effects of plant-drug interactions with a focus on anticancer strategies.
dc.description.sponsorshipThis work was partially supported by CONICYT PIA/APOYO CCTE AFB170007. Acknowledgments: N. Martins would like to thank the Portuguese Foundation for Science and Technology (FCT–Portugal) for the Strategic project ref. UID/BIM/04293/2013 and “NORTE2020—Programa Operacional Regional do Norte” (NORTE-01-0145-FEDER-000012).
dc.language.isoeng
dc.publisherMDPI
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147342/PT
dc.relation.ispartofMedicina (Lithuania), vol.55(4):110
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectAnticancer
dc.subjectConventional chemotherapeutic agents
dc.subjectPlant derivatives
dc.subjectPlant-drug interaction
dc.subjectSynergistic effects
dc.subjectSynergy
dc.subject.meshAnimals
dc.subject.meshAntineoplastic Agents / therapeutic use
dc.subject.meshDrug Antagonism
dc.subject.meshDrug Synergism
dc.subject.meshHerb-Drug Interactions
dc.subject.meshHumans
dc.subject.meshMice
dc.subject.meshNeoplasms / drug therapy
dc.subject.meshOils, Volatile / therapeutic use
dc.subject.meshPhytochemicals / therapeutic use
dc.subject.meshPhytotherapy
dc.subject.meshPolyphenols / therapeutic use
dc.subject.meshRats
dc.titleSynergistic effects of plant derivatives and conventional chemotherapeutic agents: An update on the cancer perspective
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/medicina55040110
dc.relation.publisherversionhttps://www.mdpi.com/1648-9144/55/4/110
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-medicina55040110.pdf568.13 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons